Cargando…

Autophagic- and Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and Shadows

Parkinson’s disease (PD) is a neurodegenerative disorder that currently affects 1% of the population over the age of 60 years, for which no disease-modifying treatments exist. This lack of effective treatments is related to the advanced stage of neurodegeneration existing at the time of diagnosis. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xicoy, Helena, Peñuelas, Núria, Vila, Miquel, Laguna, Ariadna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912814/ https://www.ncbi.nlm.nih.gov/pubmed/31731485 http://dx.doi.org/10.3390/cells8111317

Ejemplares similares

The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's disease
por: Kinghorn, Kerri J., et al.
Publicado: (2017)

Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder
por: Laguna, Ariadna, et al.
Publicado: (2021)

Autophagic/lysosomal dysfunction in Alzheimer’s disease
por: Orr, Miranda E, et al.
Publicado: (2013)

Autophagic lysosome reformation in health and disease
por: Nanayakkara, Randini, et al.
Publicado: (2022)

Intracellular crowding by age-dependent neuromelanin accumulation disrupts neuronal proteostasis and triggers Parkinson disease pathology
por: Vila, Miquel, et al.
Publicado: (2019)

Autophagic and endo-lysosomal dysfunction in neurodegenerative disease
por: Malik, Bilal R., et al.
Publicado: (2019)

Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s Disease
por: Blumenreich, Shani, et al.
Publicado: (2020)

In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease
por: Gonzalez-Sepulveda, Marta, et al.
Publicado: (2023)

Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease
por: Magalhaes, Joana, et al.
Publicado: (2016)

Lysosomal dysfunction–induced autophagic stress in diabetic kidney disease
por: Zheng, Hui Juan, et al.
Publicado: (2020)

The Role of Lipids in Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2019)

Inhibition of autophagic-lysosomal delivery and autophagic lactolysis by asparagine
Publicado: (1991)

Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
por: Carballo-Carbajal, Iria, et al.
Publicado: (2019)

New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
por: Lorente-Picón, Marina, et al.
Publicado: (2021)

Triamterene induces autophagic degradation of lysosome by exacerbating lysosomal integrity
por: Park, Na Yeon, et al.
Publicado: (2021)

Lysosomal Exocytosis, Exosome Release and Secretory Autophagy: The Autophagic- and Endo-Lysosomal Systems Go Extracellular
por: Buratta, Sandra, et al.
Publicado: (2020)

Development of Research into Autophagic Lysosome Reformation
por: Chen, Yang, et al.
Publicado: (2018)

Lights and Shadows
Publicado: (1897)

Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows
por: Costante, Federico, et al.
Publicado: (2022)

Lights and Shadows of Cerebrospinal Fluid Biomarkers in the Current Alzheimer’s Disease Framework
por: Gallucci, Maurizio, et al.
Publicado: (2022)

Pharmacologicaltreatment of COVID-19: lights and shadows
por: Menzella, Francesco, et al.
Publicado: (2020)

Lights and Shadows of TORCH Infection Proteomics
por: Macedo-da-Silva, Janaina, et al.
Publicado: (2020)

Lights and Shadows in Hepatic Encephalopathy Diagnosis
por: Amodio, Piero, et al.
Publicado: (2021)

Nomograms in Urologic Oncology: Lights and Shadows
por: Morlacco, Alessandro, et al.
Publicado: (2021)

Glutathione: Lights and Shadows in Cancer Patients
por: Marini, Herbert Ryan, et al.
Publicado: (2023)

Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation()
por: Manzoni, Claudia, et al.
Publicado: (2013)

The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
por: Xicoy, Helena, et al.
Publicado: (2017)

Stochastics of Degradation: The Autophagic-Lysosomal System of the Cell
por: Kudriaeva, A. A., et al.
Publicado: (2020)

New Potential Immune Biomarkers in the Era of Precision Medicine: Lights and Shadows in Colorectal Cancer
por: Damato, Angela, et al.
Publicado: (2022)

Immune-related response criteria: light and shadows
por: Merlano, Marco, et al.
Publicado: (2016)

The Emerging Role of the Lysosome in Parkinson’s Disease
por: Navarro-Romero, Alba, et al.
Publicado: (2020)

The GABA Hypothesis in Essential Tremor: Lights and Shadows
por: Gironell, Alexandre
Publicado: (2014)

Lights and Shadows on the Therapeutic Use of Antimicrobial Peptides
por: Bellotti, Denise, et al.
Publicado: (2022)

Mitohormesis and autophagic balance in Parkinson disease
por: Juarez-Flores, Diana Luz, et al.
Publicado: (2019)

Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows
por: Cassone, Giulia, et al.
Publicado: (2020)

The role of autophagic and lysosomal pathways in ischemic brain injury
por: Gu, Zhaohua, et al.
Publicado: (2013)

Rab2 promotes autophagic and endocytic lysosomal degradation
por: Lőrincz, Péter, et al.
Publicado: (2017)

Specific functions of lysosomal proteases in endocytic and autophagic pathways()
por: Müller, Sabrina, et al.
Publicado: (2012)

Lights and Shadows of Cyclophosphamide in the Treatment of Multiple Sclerosis
por: Patti, Francesco, et al.
Publicado: (2011)

Lipid rafts participate in aberrant degradative autophagic-lysosomal pathway of amyloid-beta peptide in Alzheimer's disease
por: Zhou, Xin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d4mihab9iesjqvh1l5c1pd7c22